72 reports

Major players in the ovarian cancer drugs market are AstraZeneca, Roche, Tesaro, Clovis Oncology, Boehringer Ingelheim, Amgen, GlaxoSmithKline, F. Hoffmann-La Roche AG, Bristol-Myers Squibb and Eli Lilly and Company. The global ovarian cancer drugs market is expected to grow from $2.68 billion in 2021 to $3.25 billion in 2022 at a compound...

  • Ovarian Cancer
  • World
  • Middle East
  • APAC
  • United Kingdom
  • Cancer Incidence
  • Biologics Penetration Rate

Major players in the ovarian cancer drugs market are AstraZeneca, Roche, Tesaro, Clovis Oncology,and Boehringer Ingelheim. The global ovarian cancer drugs market is expected to grow from $1.49 billion in 2020 to $1.73 billion in 2021 at a compound annual growth rate (CAGR) of 16.1%. The growth is mainly due to the companies rearranging...

  • Ovarian Cancer
  • World
  • Biologics Penetration Rate
  • Cancer Incidence

Abstract: - Global Ovarian Cancer Therapeutics Market to Reach $6.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Ovarian Cancer Therapeutics estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 18.5% over the analysis...

  • Therapy
  • Ovarian Cancer
  • World
  • China
  • United States

Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Drugs In Development, 2021, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that...

  • Ovarian Cancer
  • World

Abstract: - Global Alpha Emitters Market to Reach $5.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Alpha Emitters estimated at US$672.3 Million in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 34.1% over the analysis period 2020-2027. Melanoma,...

  • Ovarian Cancer
  • Pancreatic Cancer
  • World
  • China
  • United States

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative...

  • Ovarian Cancer

China’s demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Industrial Production
  • Labour Force

Abstract: - Global Women’s Health Diagnostics Market to Reach $48 Billion by 2027 - Amid the COVID-19 crisis, the global market for Women’s Health Diagnostics estimated at US$30.5 Billion in the year 2020, is projected to reach a revised size of US$48 Billion by 2027, growing at a CAGR of 6.7% over the analysis period...

  • Dietary Supplement
  • Diagnostics
  • Ovarian Cancer
  • World
  • China
  • United States

Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Epithelial Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Ovarian Cancer
  • World

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Ovarian Cancer
  • World

Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 Summary Cells Expressing Mucin 16 (Ovarian Cancer Related Tumor Marker CA125 or Ovarian Carcinoma Antigen CA125 or MUC16) - Drugs in Development, 2021 provides...

  • Ovarian Cancer
  • Cancer
  • World

Report Scope: This report provides an in-depth examination of the healthcare industry, with a particular emphasis on global market trend analysis.The report’s goal is to provide an overview of the market for DNA repair drugs, as well as market segmentation by type, application and geography. During the forecast period,...

  • Pharmaceutical
  • Cancer
  • Breast Cancer
  • Therapy
  • Drug Development
  • Ovarian Cancer
  • World
  • Drug Approval
  • Cancer Mortality

Ovarian Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2020, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur...

  • Ovarian Cancer
  • World

PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2020-2024 The analyst has been monitoring the parp (Poly ADP-ribose Polymerase) inhibitors market and it is poised to grow by $ 810.23 million during 2020-2024 progressing at a CAGR of 12% during the forecast period. Our reports on parp (Poly ADP-ribose Polymerase) inhibitors...

  • Breast Cancer
  • Ovarian Cancer
  • World

Ovarian Cancer Diagnostics and Therapeutics Market Report Overview Ovarian Cancer Diagnostics and Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Ovarian Cancer Diagnostics and Therapeutics market types and applications....

  • Therapy
  • Ovarian Cancer
  • World
  • Health Provider Density

5’ Nucleotidase - Pipeline Review, H1 2020 Summary According to the recently published report ’5’ Nucleotidase – Pipeline Review, H1 2020’; 5’ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) pipeline Target constitutes close to 34 molecules. Out of which approximately 31 molecules...

  • Oncology
  • Monoclonal Antibody
  • Ovarian Cancer
  • Pharmaceutical
  • World

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform - Pipeline Review, H1 2020 Summary According to the recently published report ’Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform - Pipeline Review, H1 2020’; Phosphatidylinositol 4,5 Bisphosphate...

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

Ovarian Cancer: Epidemiology Forecast to 2028 Summary Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is defined as uncontrolled cell growth in the ovaries, although research has shown that the disease may...

  • Ovarian Cancer
  • United States
  • Japan
  • World
  • Cancer Incidence
  • Mortality Rate

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform - Pipeline Review, H2 2019 Summary Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153)...

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

78 kda Glucose Regulated Protein - Pipeline Review, H2 2019 Summary 78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding Protein Grp78 or Heat Shock 70 kDa Protein 5 or Immunoglobulin Heavy Chain Binding Protein or HSPA5) pipeline Target constitutes close to 6 molecules....

  • Oncology
  • Ovarian Cancer
  • Biotechnology
  • World
  • Cancer Mortality

Ovarian Cancer Diagnostics and Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Ovarian Cancer Diagnostics and Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Ovarian Cancer...

  • Ovarian Cancer
  • Therapy
  • Diagnostics
  • World

5’ Nucleotidase - Pipeline Review, H2 2019 Summary 5’ Nucleotidase (Ecto 5’ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5?-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5’nucleotides. 5’...

  • Oncology
  • Monoclonal Antibody
  • Ovarian Cancer
  • Pharmaceutical
  • World

Community Oncology Services Market Global Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global community oncology services market. This report focuses on community oncology services market which is experiencing strong growth....

  • Clinic
  • Skin Cancer
  • Marketing Research
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Prostate Cancer
  • Renal Cancer
  • Pancreatic Cancer
  • World

This study focuses on China’s Ovarian Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Ovarian Cancer
  • China
  • Prescription Drug Sales
  • Employment Costs

This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Labour Force
  • Industrial Production

Summary ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products.The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product...

  • Cancer
  • Ovarian Cancer
  • Clinical Trial
  • Lung Cancer
  • World
  • Europe
  • United Kingdom
  • Medical Devices Sales
  • Life Expectancy

Summary Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company.The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor-specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic...

  • Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Cervical Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Clinical Trial
  • United States
  • World
  • North America
  • Medical Devices Sales

Summary IncellDx Inc (IncellDx) is a single cell diagnostic company that develops transformative diagnostic and prognostic clinical patient information technologies.The company detects and monitors life threatening viral diseases in the areas of cervical cancer, HIV and AIDS, hepatitis, and organ transplant rejection. Its...

  • Infectious Disease
  • Breast Cancer
  • Artificial Intelligence
  • Ovarian Cancer
  • Bladder Cancer
  • Clinical Trial
  • World
  • United States
  • China
  • North America
  • Medical Devices Sales

Carcinoembryonic Antigen Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Carcinoembryonic Antigen Market Size, Outlook and Growth Opportunities to 2025: By Application (Colorectal cancer, Pancreatic cancer, Breast cancer, Lung cancer, Ovarian cancer, and Others), By End User (Hospitals, Diagnostic centers,...

  • Healthcare
  • Diagnostics
  • Specialty Hospital
  • Laboratory
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Research Center
  • Pancreatic Cancer
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

The ongoing clinical trial research report- “2019 Metastatic Ovarian Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Metastatic Ovarian Cancer trials across the world. The report presents top level analysis of global Metastatic Ovarian Cancer clinical trials across countries, companies and universities. It...

  • Ovarian Cancer
  • Clinical Trial
  • World
  • APAC